These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10654584)

  • 1. Activation of 5-HT2A/2C receptors within the nucleus accumbens increases local dopaminergic transmission.
    Yan QS
    Brain Res Bull; 2000 Jan; 51(1):75-81. PubMed ID: 10654584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation.
    De Deurwaerdère P; Spampinato U
    J Neurochem; 1999 Sep; 73(3):1033-42. PubMed ID: 10461892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens.
    Willins DL; Meltzer HY
    Brain Res; 1998 Jan; 781(1-2):291-9. PubMed ID: 9507167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced accumbal dopamine release following 5-HT(2A) receptor stimulation in rats pretreated with intermittent cocaine.
    Yan Q; Reith ME; Yan S
    Brain Res; 2000 Apr; 863(1-2):254-8. PubMed ID: 10773215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of 5-HT(1B/1D) receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study.
    Yan QS; Yan SE
    Eur J Pharmacol; 2001 Apr; 418(1-2):55-64. PubMed ID: 11334865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
    Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies.
    Broderick PA; Olabisi OA; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):547-57. PubMed ID: 15093963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin 5-HT(2) receptor stimulation of dopamine release in the posterior but not anterior nucleus accumbens of the rat.
    Bowers BJ; Henry MB; Thielen RJ; McBride WJ
    J Neurochem; 2000 Oct; 75(4):1625-33. PubMed ID: 10987844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective blockade of serotonin2C/2B receptors enhances dopamine release in the rat nucleus accumbens.
    Di Matteo V; Di Giovanni G; Di Mascio M; Esposito E
    Neuropharmacology; 1998; 37(2):265-72. PubMed ID: 9680252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.
    Porras G; Di Matteo V; Fracasso C; Lucas G; De Deurwaerdère P; Caccia S; Esposito E; Spampinato U
    Neuropsychopharmacology; 2002 Mar; 26(3):311-24. PubMed ID: 11850146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal bicuculline increases extracellular dopamine concentration in the nucleus accumbens of freely moving rats as measured by in vivo microdialysis.
    Yan Q
    Eur J Pharmacol; 1999 Nov; 385(1):7-13. PubMed ID: 10594339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors.
    Navailles S; Moison D; Ryczko D; Spampinato U
    J Neurochem; 2006 Nov; 99(4):1311-9. PubMed ID: 17018023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
    Ichikawa J; Meltzer HY
    Brain Res; 2000 Mar; 858(2):252-63. PubMed ID: 10708676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study.
    Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E
    Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin 2A receptor regulation of striatal neuropeptide gene expression is selective for tachykinin, but not enkephalin neurons following dopamine depletion.
    Basura GJ; Walker PD
    Brain Res Mol Brain Res; 2001 Aug; 92(1-2):66-77. PubMed ID: 11483243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism.
    Bishop C; Tessmer JL; Ullrich T; Rice KC; Walker PD
    J Pharmacol Exp Ther; 2004 Aug; 310(2):687-94. PubMed ID: 15044557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Bonaccorso S; Meltzer HY; Li Z; Dai J; Alboszta AR; Ichikawa J
    Neuropsychopharmacology; 2002 Sep; 27(3):430-41. PubMed ID: 12225700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release.
    Ichikawa J; Dai J; Meltzer HY
    Brain Res; 2001 Jul; 907(1-2):151-5. PubMed ID: 11430898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors.
    Di Matteo V; Di Giovanni G; Di Mascio M; Esposito E
    Brain Res; 2000 May; 865(1):85-90. PubMed ID: 10814735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study.
    Di Giovanni G; De Deurwaerdére P; Di Mascio M; Di Matteo V; Esposito E; Spampinato U
    Neuroscience; 1999; 91(2):587-97. PubMed ID: 10366016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.